메뉴 건너뛰기




Volumn 48, Issue 9, 2013, Pages 1192-1197

Second hematopoietic SCT for leukemia relapsing after myeloablative T cell-depleted transplants does not prolong survival

Author keywords

Leukemia; Relapse; Second SCT; Survival; T depleted

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; IDARUBICIN; MELPHALAN; PREDNISONE; RITUXIMAB; VINCRISTINE;

EID: 84883737540     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2013.39     Document Type: Article
Times cited : (13)

References (20)
  • 1
    • 77955595601 scopus 로고    scopus 로고
    • Relapse after allogeneic stem cell transplantation
    • Barrett AJ, Battiwalla M. Relapse after allogeneic stem cell transplantation. Expert Rev Hematol 2010; 3: 429-441.
    • (2010) Expert Rev Hematol , vol.3 , pp. 429-441
    • Barrett, A.J.1    Battiwalla, M.2
  • 2
    • 58149178882 scopus 로고    scopus 로고
    • Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant
    • Shaw BE, Mufti GJ, Mackinnon S, Cavenagh JD, Pearce RM, Towlson KE et al. Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant. Bone Marrow Transplant 2008; 42: 783-789.
    • (2008) Bone Marrow Transplant , vol.42 , pp. 783-789
    • Shaw, B.E.1    Mufti, G.J.2    MacKinnon, S.3    Cavenagh, J.D.4    Pearce, R.M.5    Towlson, K.E.6
  • 3
    • 36348989592 scopus 로고    scopus 로고
    • Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation
    • Pollyea DA, Artz AS, Stock W, Daugherty C, Godley L, Odenike OM et al. Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2007; 40: 1027-1032.
    • (2007) Bone Marrow Transplant , vol.40 , pp. 1027-1032
    • Pollyea, D.A.1    Artz, A.S.2    Stock, W.3    Daugherty, C.4    Godley, L.5    Odenike, O.M.6
  • 4
  • 6
    • 0021970007 scopus 로고
    • How should acute lymphoblastic leukaemia relapsing after bone-marrow transplantation be treated?
    • Barrett AJ, Joshi R, Tew C. How should acute lymphoblastic leukaemia relapsing after bone-marrow transplantation be treated? Lancet 1985; 1: 1188-1191.
    • (1985) Lancet , vol.1 , pp. 1188-1191
    • Barrett, A.J.1    Joshi, R.2    Tew, C.3
  • 7
    • 74049150759 scopus 로고    scopus 로고
    • A multi-center phase i study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia
    • Hijiya N, Gaynon P, Barry E, Silverman L, Thomson B, Chu R et al. A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia. Leukemia 2009; 23: 2259-2264.
    • (2009) Leukemia , vol.23 , pp. 2259-2264
    • Hijiya, N.1    Gaynon, P.2    Barry, E.3    Silverman, L.4    Thomson, B.5    Chu, R.6
  • 8
    • 40749121702 scopus 로고    scopus 로고
    • Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation
    • Loren AW, Porter DL. Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation. Bone Marrow Transplant 2008; 41: 483-493.
    • (2008) Bone Marrow Transplant , vol.41 , pp. 483-493
    • Loren, A.W.1    Porter, D.L.2
  • 9
    • 80054759339 scopus 로고    scopus 로고
    • Prevention and treatment of acute myeloid leukemia relapse after allogeneic stem cell transplantation
    • Oran B, de Lima M. Prevention and treatment of acute myeloid leukemia relapse after allogeneic stem cell transplantation. Curr Opin Hematol 2011; 18: 388-394.
    • (2011) Curr Opin Hematol , vol.18 , pp. 388-394
    • Oran, B.1    De Lima, M.2
  • 10
    • 0742323848 scopus 로고    scopus 로고
    • Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure
    • Nakamura R, Battiwalla M, Solomon S, Follmann D, Chakrabarti S, Cortez K et al. Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure. Biol Blood Marrow Transplant 2004; 10: 49-57.
    • (2004) Biol Blood Marrow Transplant , vol.10 , pp. 49-57
    • Nakamura, R.1    Battiwalla, M.2    Solomon, S.3    Follmann, D.4    Chakrabarti, S.5    Cortez, K.6
  • 11
    • 0038413491 scopus 로고    scopus 로고
    • Cyclosporine is required to prevent severe acute GVHD following T-cell-depleted peripheral blood stem cell transplantation
    • Solomon SR, Nakamura R, Read EJ, Leitman SF, Carter C, Childs R et al. Cyclosporine is required to prevent severe acute GVHD following T-cell-depleted peripheral blood stem cell transplantation. Bone Marrow Transplant 2003; 31: 783-788.
    • (2003) Bone Marrow Transplant , vol.31 , pp. 783-788
    • Solomon, S.R.1    Nakamura, R.2    Read, E.J.3    Leitman, S.F.4    Carter, C.5    Childs, R.6
  • 12
    • 84862000695 scopus 로고    scopus 로고
    • Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT
    • Spyridonidis A, Labopin M, Schmid C, Volin L, Yakoub-Agha I, Stadler M et al. Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT. Leukemia 2012; 26: 1211-1217.
    • (2012) Leukemia , vol.26 , pp. 1211-1217
    • Spyridonidis, A.1    Labopin, M.2    Schmid, C.3    Volin, L.4    Yakoub-Agha, I.5    Stadler, M.6
  • 13
    • 79952590640 scopus 로고    scopus 로고
    • Donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation
    • Roddie C, Peggs KS. Donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation. Expert Opin Biol Ther 2011; 11: 473-487.
    • (2011) Expert Opin Biol Ther , vol.11 , pp. 473-487
    • Roddie, C.1    Peggs, K.S.2
  • 15
    • 36348967686 scopus 로고    scopus 로고
    • Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation
    • Oran B, Giralt S, Couriel D, Hosing C, Shpall EJ, de Meis E et al. Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation. Leukemia 2007; 21: 2540-2544.
    • (2007) Leukemia , vol.21 , pp. 2540-2544
    • Oran, B.1    Giralt, S.2    Couriel, D.3    Hosing, C.4    Shpall, E.J.5    De Meis, E.6
  • 16
    • 84877648195 scopus 로고    scopus 로고
    • Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia
    • Poon LM, Bassett Jr R, Rondon G, Hamdi A, Qazilbash M, Hosing C et al. Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia. Bone Marrow Transplant 2013; 48: 666-670.
    • (2013) Bone Marrow Transplant , vol.48 , pp. 666-670
    • Poon, L.M.1    Bassett Jr., R.2    Rondon, G.3    Hamdi, A.4    Qazilbash, M.5    Hosing, C.6
  • 17
    • 84859582203 scopus 로고    scopus 로고
    • Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)
    • Goodyear OC, Dennis M, Jilani NY, Loke J, Siddique S, Ryan G et al. Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML). Blood 2012; 119: 3361-3369.
    • (2012) Blood , vol.119 , pp. 3361-3369
    • Goodyear, O.C.1    Dennis, M.2    Jilani, N.Y.3    Loke, J.4    Siddique, S.5    Ryan, G.6
  • 19
    • 79952129510 scopus 로고    scopus 로고
    • Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: Myths, controversies, and unknowns
    • Gupta V, Tallman MS, Weisdorf DJ. Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns. Blood 2011; 117: 2307-2318.
    • (2011) Blood , vol.117 , pp. 2307-2318
    • Gupta, V.1    Tallman, M.S.2    Weisdorf, D.J.3
  • 20
    • 77951257237 scopus 로고    scopus 로고
    • Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens
    • Warren EH, Fujii N, Akatsuka Y, Chaney CN, Mito JK, Loeb KR et al. Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens. Blood 2010; 115: 3869-3878.
    • (2010) Blood , vol.115 , pp. 3869-3878
    • Warren, E.H.1    Fujii, N.2    Akatsuka, Y.3    Chaney, C.N.4    Mito, J.K.5    Loeb, K.R.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.